In vitro activity of norfloxacin against Chlamydia trachomatis.
D000900:Anti-Bacterial Agents / Q000633:toxicity*; D002692:Chlamydia trachomatis / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000633:toxicity; D009643:Norfloxacin; D013045:Species Specificity; D014526:Urethritis / Q000382:microbiology
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D009643:Norfloxacin